Pediatric subspecialists fail to follow guidelines for treating ADHD
More than 90% of pediatric subspecialists who diagnose and manage attention-deficit/hyperactivity disorder (ADHD) in young children deviate from current recommendations of the American Academy of Pediatrics (AAP) and the American Academy of Child and Adolescent Psychiatry regarding treatment of pediatric ADHD.
More than 90% of pediatric subspecialists who diagnose and manage attention-deficit/hyperactivity disorder (ADHD) in young children deviate from current recommendations of the American Academy of Pediatrics (AAP) and the American Academy of Child and Adolescent Psychiatry regarding treatment of pediatric ADHD.
Clinical guidelines advise that preschoolers with ADHD receive initial treatment with behavior modification, followed by pharmacotherapy with the first-line medication methylphenidate when behavior modification is not successful.
Preliminary data from a survey of 560 board-certified pediatric subspecialists including developmental-behavioral pediatricians, child psychiatrists, and child neurologists revealed that just 8%, 12%, and 9%, respectively, complied with the clinical guidelines.
One in 5 respondents reported using medication as first-line treatment often or very often. Among all respondents who prescribed medication for initial treatment of pediatric ADHD, more than one-third reported choosing amphetamines or nonstimulants rather than methylphenidate. There were no differences across subspecialties regarding initiation of medication or selection criteria.
The researchers say it is unclear why so many clinicians who specialize in management of ADHD fail to comply with treatment guidelines.
Chung J, Sunday S, Meryash D, Gutman A, Adesman A. Medication management of preschool ADHD by pediatric sub-specialists: non-compliance with AAP clinical guidelines. Paper presented at: Pediatric Academic Societies Annual Meeting; May 2012; Washington, DC.
Exome sequencing should be used for diagnosing cerebral palsy
October 13th 2023A systematic review and meta-analysis found that such sequencing indeed has an equivalent high genetic diagnostic yield in cerebral palsy, which supports including this neurodevelopmental disorder among those for which diagnostic exome sequencing should be used.
Is ADHD associated with shorter-than-expected height?
October 10th 2023To assess the role of familial factors, investigators analyzed data for a family-based group created from another Swedish national register that included 833,172 individuals without ADHD with different levels of relatedness to the individuals with ADHD and a group of matched controls.
Associations between prenatal metal mixture exposure and negative infant outcomes
September 19th 2023Francheska M. Merced-Nieves, PhD, Assistant professor, Departments of Pediatrics and the Institute for Exposomic Research of Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, explains the associations prenatal exposure to a metal mixture and the potential negative effects for the infant.
